Vol. 52 No. 3 (2013): Acta Oncologica

Articles

• Early prediction of pathological response in locally advanced rectal cancer based on sequential 18F-FDG PET

  Mathieu Hatt, Ruud van Stiphout, Adrien le Pogam, Guido Lammering, Dimitris Visvikis, Philippe Lambin

  619-626

  Published: 2013-04-01

  • PDF

• Improved tumour control probability with MRI-based prostate brachytherapy treatment planning

  Anna M. Dinkla, Bradley R. Pieters, Kees Koedooder, Niek van Wieringen, Rob van der Laarse, Johan N. van der Grient, Coen R. Rasch, Caro C. Koning, Arjan Bel

  658-665

  Published: 2013-04-01

  • PDF

• Outcomes in men with large prostates (≥ 60 cm3) treated with definitive proton therapy for prostate cancer

  Lisa Mcgee, Nancy P. Mendenhall, Randal H. Henderson, Christopher G. Morris, Romaine C. Nichols Jr, Robert J. Marcus Jr, Zuofeng Li, William M. Mendenhall, Christopher R. Williams, Bradford S. Hoppe

  470-476

  Published: 2013-04-01

  • PDF

• Dosimetric rationale and early experience at UFPTI of thoracic proton therapy and chemotherapy in limited-stage small cell lung cancer

  Rovel J. Colaco, Soon Huh, Romaine C. Nichols, Christopher G. Morris, Harry D’Agostino, Stella Flampouri, Zuofeng Li, Dat C. Pham, Abubakr A. Bajwa, Bradford S. Hoppe

  506-513

  Published: 2013-04-01

  • PDF

• Dosimetric comparison between VMAT with different dose calculation algorithms and protons for soft-tissue sarcoma radiotherapy

  Antonella Fogliata, Marta Scorsetti, Piera Navarria, Maddalena Catalano, Alessandro Clivio, Luca Cozzi, Francesca Lobefalo, Giorgia Nicolini, Valentina Palumbo, Chiara Pellegrini, Giacomo Reggiori, Antonella Roggio, Eugenio Vanetti, Filippo Alongi, Sara Pentimalli, Pietro Mancosu

  545-552

  Published: 2013-04-01

  • PDF

• Particle species dependence of cell survival RBE: Evident and not negligible

  Thomas Friedrich, Marco Durante, Michael Scholz

  589-603

  Published: 2013-04-01

  • PDF

• Dynamic contrast-enhanced magnetic resonance imaging of the metastatic potential of tumors: A preclinical study of cervical carcinoma and melanoma xenografts

  Kirsti Marie Øvrebø, Christine Ellingsen, Tord Hompland, Einar K. Rofstad

  604-611

  Published: 2013-04-01

  • PDF

• Treatment plan comparison using grading analysis based on clinical judgment

  Kristoffer Petersson, Jacob Engellau, Per Nilsson, Per Engström, Tommy Knöös, Crister Ceberg

  645-651

  Published: 2013-04-01

  • PDF

• Establishing and expanding the indications for proton and particle therapy

  Ludvig P. Muren, Carl Rossi, Eugen Hug, Andrew Lee, Bengt Glimelius

  459-462

  Published: 2013-04-01

  • PDF

• Hypofractionated passively scattered proton radiotherapy for low- and intermediate-risk prostate cancer is not associated with post-treatment testosterone suppression

  Whoon Jong Kil, Romaine C. Nichols Jr, Bradford S. Hoppe, Christopher G. Morris, Robert B. Marcus Jr, William Mendenhall, Nancy P. Mendenhall, Zuofeng Li, Joseph A. Costa, Christopher R. Williams, Randal H. Henderson

  492-497

  Published: 2013-04-01

  • PDF

• Integrated peripheral boost in preoperative radiotherapy for the locally most advanced non-resectable rectal cancer patients

  Calin Radu, Ola Norrlid, Morten Brændengen, Karl Hansson, Ulf Isacsson, Bengt Glimelius

  528-537

  Published: 2013-04-01

  • PDF

• Robustness of IMPT treatment plans with respect to inter-fractional set-up uncertainties: Impact of various beam arrangements for cranial targets

  Johannes Hopfgartner, Markus Stock, Barbara Knäusl, Dietmar Georg

  570-579

  Published: 2013-04-01

  • PDF

• A treatment planning comparison of highly conformal radiation therapy for pediatric low-grade brainstem gliomas

  Jeffrey V. Brower, Daniel J. Indelicato, Philipp R. Aldana, Eric Sandler, Ronny Rotondo, Nancy P. Mendenhall, Robert B. Marcus, Zhong Su

  594-599

  Published: 2013-04-01

  • PDF

• Assessment of the interstitial fluid pressure of tumors by dynamic contrast-enhanced magnetic resonance imaging with contrast agents of different molecular weights

  Tord Hompland, Kristine Gulliksrud, Christine Ellingsen, Einar K. Rofstad

  627-635

  Published: 2013-04-01

  • PDF

• Statistical simulations to estimate motion-inclusive dose-volume histograms for prediction of rectal morbidity following radiotherapy

  Maria Thor, Aditya Apte, Joseph O. Deasy, Ludvig Paul Muren

  666-675

  Published: 2013-04-01

  • PDF

• A phase II study of hypofractionated proton therapy for prostate cancer

  Yeon-Joo Kim, Kwan Ho Cho, Hong Ryull Pyo, Kang Hyun Lee, Sung Ho Moon, Tae Hyun Kim, Kyung Hwan Shin, Joo-Young Kim, Se Byeong Lee, Byong Ho Nam

  477-485

  Published: 2013-04-01

  • PDF

• Prospective evaluation of early treatment outcome in patients with meningiomas treated with particle therapy based on target volume definition with MRI and 68Ga-DOTATOC-PET

  Stephanie E. Combs, Thomas Welzel, Daniel Habermehl, Stefan Rieken, Jan-Oliver Dittmar, Kerstin Kessel, Oliver Jäkel, Uwe Haberkorn, Jürgen Debus

  514-520

  Published: 2013-04-01

  • PDF

• Dosimetric comparison between proton and photon beams in the moving gap region in cranio-spinal irradiation (CSI)

  Chee-Wai Cheng, Indra J. Das, Shiv P. Srivastava, Li Zhao, Mark Wolanski, Joseph Simmons, Peter A.S. Johnstone, Jeffrey C. Buchsbaum

  553-560

  Published: 2013-04-01

  • PDF

• In response to the commentary ‘Particle species dependence of cell survival relative biological effectiveness: Evident and not negligible’ by Thomas Friedrich, Marco Durante & Michael Scholz

  Brita Singers Sørensen, Jens Overgaard, Niels Bassler

  591

  Published: 2013-04-01

  • PDF

• T1/T2*-weighted MRI provides clinically relevant pseudo-CT density data for the pelvic bones in MRI-only based radiotherapy treatment planning

  Mika Kapanen, Mikko Tenhunen

  612-618

  Published: 2013-04-01

  • PDF

• Comparable cell survival between high dose rate flattening filter free and conventional dose rate irradiation

  Wilko F.A.R. Verbakel, Jaap van den Berg, Ben J. Slotman, Peter Sminia

  652-657

  Published: 2013-04-01

  • PDF

• Urinary functional outcomes and toxicity five years after proton therapy for low- and intermediate-risk prostate cancer: Results of two prospective trials

  Randal H. Henderson, Bradford S. Hoppe, Robert B. Marcus Jr, William M. Mendenhall, R. Charles Nichols, Zuofeng Li, Zhong Su, Christopher G. Morris, Christopher R. Williams, Joseph Costa, Nancy P. Mendenhall

  463-469

  Published: 2013-04-01

  • PDF

• Proton therapy with concomitant capecitabine for pancreatic and ampullary cancers is associated with a low incidence of gastrointestinal toxicity

  R. Charles Nichols Jr, Thomas J. George, Robert A. Zaiden Jr, Ziad T. Awad, Horacio J. Asbun, Soon Huh, Meng Wei Ho, Nancy P. Mendenhall, Christopher G. Morris, bradford S. Hoppe

  498-505

  Published: 2013-04-01

  • PDF

• Dose-volume histogram analysis for risk factors of radiation-induced rib fracture after hypofractionated proton beam therapy for hepatocellular carcinoma

  Ayae Kanemoto, Masashi Mizumoto, Toshiyuki Okumura, Hideto Takahashi, Takayuki Hashimoto, Yoshiko Oshiro, Nobuyoshi Fukumitsu, Takashi Moritake, Koji Tsuboi, Takeji Sakae, Hideyuki Sakurai

  538-544

  Published: 2013-04-01

  • PDF

• A model for the relative biological effectiveness of protons: The tissue specific parameter α/β of photons is a predictor for the sensitivity to LET changes

  Minna Wedenberg, Bengt K. Lind, Björn Hårdemark

  580-588

  Published: 2013-04-01

  • PDF

• Proton beam therapy for unresectable hepatoblastoma in children: Survival in one case

  Yoshiko Oshiro, Toshiyuki Okumura, Masashi Mizumoto, Takashi fukushima, Hitoshi Ishikawa, Takayuki Hashimoto, Koji Tsuboi, Michio Kaneko, Hideyuki Sakurai

  600-603

  Published: 2013-04-01

  • PDF

• A gel tumour phantom for assessment of the accuracy of manual and automatic delineation of gross tumour volume from FDG-PET/CT

  Arne Skretting, an F. Evensen, Ayca M. Løndalen, Trond V. Bogsrud, Otto K. Glomset, Karsten Eilertsen

  636-644

  Published: 2013-04-01

  • PDF

• Tumor size does not predict pathological complete response rates after pre-operative chemoradiotherapy for non-small cell lung cancer

  Cornelis G. Vos, Max Dahele, Chris Dickhoff, Suresh Senan, Erik Thunnissen, Koen J. Hartemink

  676-678

  Published: 2013-04-01

  • PDF

• Hip fractures and pain following proton therapy for management of prostate cancer

  Raul Valery, Nancy P. Mendenhall, Romaine C. Nichols Jr, Randal Henderson, Christopher G. Morris, Zhong Su, William M. Mendenhall, Christopher R. Williams, Zuofeng Li, Bradford S. Hoppe

  486-491

  Published: 2013-04-01

  • PDF

• Degradation of target coverage due to inter-fraction motion during intensity-modulated proton therapy of prostate and elective targets

  Sara Thörnqvist, Ludvig P. Muren, Lise Bentzen, Liv B. Hysing, Morten Høyer, Cai Grau, Jørgen B. B. Petersen

  521-527

  Published: 2013-04-01

  • PDF

• The potential of intensity-modulated proton radiotherapy to reduce swallowing dysfunction in the treatment of head and neck cancer: A planning comparative study

  Hans Paul van der Laan, Tara A. van de Water, Heleen E. van Herpt, Miranda E. M. C. Christianen, Hendrik P. Bijl, Erik. W. Korevaar, Coen R. Rasch, Aart A. van ‘T Veld, Arjen van der Schaaf, Cornelis Schilstra, Johannes A. Langendijk

  561-569

  Published: 2013-04-01

  • PDF

• Proton therapy in a pediatric patient with stage III Hodgkin lymphoma

  Adam Holtzman, Stella Flampouri, Zuofeng Li, Nancy P. Mendenhall, Bradford S. Hoppe

  592-594

  Published: 2013-04-01

  • PDF